TCI GENE Inc.
6879
Rank in Stocks
#25056
TCI GENE Inc., based in Taipei, Taiwan, specializes in delivering personalized... TCI GENE Inc., based in Taipei, Taiwan, specializes in delivering personalized preventative healthcare solutions. The company offers an extensive range of genetic screenings, including tests for nutrient metabolism, weight management, and specific G2 and ACE2 markers. Its diverse product portfolio encompasses dietary supplements, skincare items, anti-aging treatments, products designed to support children's development, and solutions targeting Alzheimer's disease. Additionally, TCI GENE provides specialized serums for DNA typing and offers professional nutrition counseling services.
Share Price
$1.08
Last synced: 2026-11-10
Market Cap
$28.63M
Change (1 day)
-0.70%
Change (1 year)
-16.15%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TCI GENE Inc. (6879)
Category
Healthcare
EPS for TCI GENE Inc. (6879)
EPS as of June 2026 TTM: $0.06
According to TCI GENE Inc.'s latest financial reports, its current EPS (TTM) is $0.06. At the end of 2025 the company had an EPS of $0.05, a decrease compared to its 2024 EPS of $0.06.
EPS history for TCI GENE Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.06 | 18.60% |
| 2025 | $0.05 | -24.46% |
| 2024 | $0.06 | 351.75% |
| 2023 | $0.01 | -85.14% |
| 2022 | $0.10 | -44.90% |
| 2021 | $0.17 | 152.68% |
| 2020 | $0.07 | -32.65% |
| 2019 | $0.10 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 26,308.09% |
US
|
|
| $-7.07 | -12,022.43% |
US
|
|
| $-5.29 | -9,020.74% |
AU
|
|
| $12.88 | 21,620.24% |
BE
|
|
| $21.56 | 36,257.50% |
NL
|
Questions about TCI GENE Inc.'s earnings per share (EPS)
What is TCI GENE Inc.'s earnings per share (EPS)?
TCI GENE Inc.'s earnings per share (EPS) over the last twelve months is $0.06, as of Jun 2026.
What was TCI GENE Inc.'s earnings per share (EPS) in 2025?
In 2025, TCI GENE Inc.'s earnings per share (EPS) was $0.05, 16.67% less than in 2024 ($0.06).
How has TCI GENE Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, TCI GENE Inc.'s earnings per share (EPS) went from $0.07 to $0.05, an average decline of 6.51% a year.
How does TCI GENE Inc.'s earnings per share (EPS) compare with similar companies?
TCI GENE Inc.'s earnings per share (EPS) ($0.06) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.